Nanoviricides NNVC Institutional Ownership

Updated Oct 10, 2026

Nanoviricides, Inc. (NYSE:NNVC) counted 49 institutional investors among its 13F-reported shareholders for the quarter ended June 30, 2026.

• Together they owned 10.32% of the outstanding stock in Q2 2026, up from 8.78% a quarter earlier.
• Total shares held in Nanoviricides rose 24.91% versus Q1 2026, while the number of holders rose 53.12% versus Q2 2025.
• Among the 49 holders of Nanoviricides, 19 added to their positions, 5 reduced their stakes and 25 left their positions unchanged.
• Institutional investors held 2.37Mn shares of Nanoviricides in total at the end of Q2 2026, up 473.3K from the prior quarter and up 1.04Mn from a year earlier.
• Vanguard Capital Management LLC was the top holder of Nanoviricides as of June 30, 2026, with 919.31K shares, or 4.00% of shares outstanding.
• The biggest increases in NNVC positions during Q2 2026 came from Vanguard Capital Management LLC (+407.84K shares), Vanguard Fiduciary Trust Co (+41.86K shares), Northern Trust Corp (+27.01K shares), Miller Financial Services LLC (+7K shares) and Osaic Holdings, Inc. (+1.7K shares).
• Holders that trimmed the most shares of Nanoviricides in Q2 2026 while keeping a position were UBS Group AG (-114.03K shares), Susquehanna International Group, LLP (-38.41K shares), Geode Capital Management, LLC (-9.36K shares), Renaissance Technologies LLC (-6.3K shares) and Tower Research Capital LLC (-3.27K shares).
• According to Business Quant data, the leading holders of NNVC for Q2 2026 were Vanguard Capital Management LLC (919.31K shares), Geode Capital Management, LLC (216.02K shares), Connective Capital Management, LLC (185.22K shares), BlackRock, Inc. (158.75K shares), Vanguard Fiduciary Trust Co (131.92K shares), Renaissance Technologies LLC (128.6K shares), Miller Financial Services LLC (112K shares), UBS Group AG (99.33K shares), Creative Planning (86.76K shares) and Susquehanna International Group, LLP (60.62K shares).